Free Yourself From Glasses and Contacts

The EVO/EVO+ ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with up to 6 D of astigmatism for patients who are 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens. Implantation of the EVO/EVO+ ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse events: additional surgeries, cataract formation, transient or persistent loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, corneal swelling, conjunctival irritation, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO/EVO+ ICL dislocation, macular edema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO/EVO+ ICL surgery you should have a complete eye examination and talk with your eye care professional about the EVO/EVO+ ICL procedure, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.